LLY Eli Lilly
$1,157 +1.26%
US Stock · Healthcare
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+1.26%
YTD
+37.20%
P/E
40.42
P/B
38.29
ROE
92.6%
Div yield
0.8%
Beta
0.29
Market cap
$1.08T
RSI (14)
48
Next earnings
Oct 29, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$1,147
Close
$1,157
VWAP (n/a)
—
Day high
$1,177
Day low
$1,140
Volume
2.1M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
Yahoo Finance · Oct 6
Prediction: LLY Has Another Massive Growth Opportunity Beyond Weight Loss
Yahoo Finance · Oct 6
General Medicine Raises $120 Million to Build the Healthcare Store
Yahoo Finance · Oct 6
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance · Oct 6
Foundayo Showed Better Results Than Oral Semaglutide in a New Analysis. There’s a Catch Investors Shouldn’t Miss
Yahoo Finance · Oct 6
Lilly deepens ties with Gate Bioscience in $870m deal expansion
Yahoo Finance · Oct 6
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 5, 2026 View → 8-K Aug 5, 2026 View → 8-K May 20, 2026 View → 8-K May 7, 2026 View → 10-Q Apr 30, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell LLY. Try it in the Lab to size a position and see the risk.